Related Experiment Video

Updated: Jun 26, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation?

B Dahlbäck1, L B Nielsen

  • 1Department of Laboratory Medicine, University Hospital, University of Lund, Malmö, Sweden. bjorn.dahlback@med.lu.se

Cellular and Molecular Life Sciences : CMLS
|January 21, 2009
PubMed

Insights

Apolipoprotein M (apoM) is a protein in high-density lipoproteins (HDL) that may influence cholesterol metabolism. Studies suggest apoM has antiatherogenic properties, potentially protecting against coronary heart disease (CHD).

Area of Science:

  • Biochemistry
  • Lipid Metabolism
  • Cardiovascular Research

Background:

  • Apolipoprotein M (apoM) is a novel apolipoprotein predominantly found in high-density lipoproteins (HDL).
  • Its precise physiological function and role in lipid metabolism remain largely undefined.
  • ApoM possesses a characteristic lipocalin structure with a hydrophobic pocket, capable of binding ligands like retinoids, albeit with low affinity.

Purpose of the Study:

  • To investigate the function and metabolic implications of apolipoprotein M.
  • To explore the relationship between apoM levels and cardiovascular health, particularly coronary heart disease (CHD).
  • To elucidate potential antiatherogenic mechanisms mediated by apoM.

Main Methods:

  • Analysis of apoM concentration in plasma and its correlation with lipid profiles (HDL and LDL cholesterol).
  • Case-control studies comparing apoM levels in patients with CHD and healthy controls.
  • Experiments utilizing transgenic mice to assess the in vivo effects of apoM on atherogenesis.

Main Results:

  • Plasma apoM levels show a strong correlation with both HDL and LDL cholesterol concentrations, indicating a link to cholesterol metabolism.
  • Case-control studies found no significant difference in apoM levels between CHD patients and controls, suggesting apoM may not be a direct risk factor for CHD in humans.
  • Transgenic mouse studies indicated potential antiatherogenic properties of apoM.

Conclusions:

  • Apolipoprotein M is associated with cholesterol metabolism and HDL composition.
  • While not directly linked to CHD risk in humans, apoM may exert protective effects against atherosclerosis through mechanisms like enhanced pre-beta HDL formation, cholesterol mobilization, and antioxidant activity.

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Related Concept Videos

Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...